E-drug: the 39 Suing in South Africa (cont)
---------------------------------------------
Here are they again but including some of the addresses.
DON'T FORGET TO SIGN THE DROP THE CASE PETITION IF YOU HAVE NOT DONE SO AT:
WWW.MSF.ORG
I will be in South Africa for the court case next week We will keep you posted.
Ellen 't Hoen
MSF
Ellen.t.hoen@paris.msf.org
South Africa Medicines Act Case
39 company contact info:
(After mergers and subsidiaries are taken into consideration, there
are 20 multinational companies (addresses below), two South African
companies, and one lobbying group.)
1. Mr. Van Steenbergen
Director General
Janssen-Cilag
Uitbreidingstraat, 2
2600 Berchem
Belgium
2. Raymond V. Gilmartin
Chairman, President and Chief Executive Officer Merck & Co., Inc.
One Merck Drive
P.O. Box 100
Whitehouse Station, New Jersey 08889-0100
USA
Fax: (908) 735-1253
3. Charles A. Heimbold, Jr.
Chairman and Chief Executive Officer Bristol-Myers Squibb Company
345 Park Avenue
New York, New York 10154-0037
USA
Fax: (212) 546-4020
4. Sidney Taurel
Chairman, President, and Chief Executive Officer Eli Lilly & Co.
Lilly Corporate Center
Indianapolis, Indiana 46285
USA
Fax: (317) 276-3492
5. Richard Kogan
Chairman & Chief Executive Officer
Schering-Plough Corp.
One Giralda Farms
Madison, New Jersey 07940
USA
Fax: (908) 298-7082
6. Bernard Poussot
President
Wyeth-Ayerst Pharmaceuticals
555 Lancaster Avenue
St. Davids, Pennsylvania 19087
USA
Fax: (610) 688-9498
7. Tim Sear
President & Chief Executive Officer
Alcon Laboratories, Inc.
6201 South Freeway
Fort Worth, Texas 76134
USA
Fax: (817) 568-7131
8. Fred Hassan
Chief Executive Officer
Pharmacia Corporation
100 Route 206 North
Peapack, New Jersey 07977
USA
Fax: (908) 901-8379
9. Dr Tom McKillop
Astra Zeneca plc
15 Stanhope Gate
London
W1K 1LN
United Kingdom
10. Dr J P Garnier
Glaxo SmithKline plc
New Horizons Court
Great West Road
Brentford
Middlesex
TW8 4EP
United Kingdom
11. Erik Sprunk-Jansen
H. Lundbeck A/S
Ottiliavej 9
DK-2500 Valby
Denmark
Tel: +45 3630 1311
Fax: +45 3630 1940
12. Lars Rebien Sorensen
Novo Nordisk A/S
Novo All�
Dk-2880 Bagsvaerd
Denmark
Tel: +45 4444 8888
Fax: +45 4449 0555
13. Boehringer Ingelheim International
Boehringer Ingelheim KG
Ingelheim Pharmaceuticals Limited
Dr. Karl Thomae GmbH
Boehringer Ingelheim Pharma KG
Binger Stra�e
55216 Ingelheim
Germany
Tel.:+49 � (0)6132 � 770
Fax: +49 � (0)6132 � 77-30 00
14. Byk Gulden Lomberg
Byk Madaus
Byk Gulden Lomberg Chemische Fabrik GmbH
Byk Gulden Str. 2
78467 Konstanz
Germany
Tel.: +49-(0)7531 � 84-0
Fax: +49-(0)7531- 842474
15. Knoll Deutschland GmbH
Rathausplatz 10-12
67059 Ludwigshafen
Germany
Tel.: +49-(0)0621-594-0
Fax: +49-(0)621- 594-17 71
16. Bayer AG
Bayer (Proprietary) Limited
Bayer Vital GmbH & Co. KG
51368 Leverkusen
Germany
Tel.: +49-(0)214 � 30-1
17. Aventis Pharma
Directeur G�n�ral : Mr. Richard J Markham
10, rue de la Paix
75002 PARIS
France
Tel : 01 40 15 91 92
Fax : 01 40 15 94 93
www.laboratoire-aventis.com
18. Janssen Cilag AG
Mr Peer NORKJAER
SIHLBRUGGSTRASSE 111
6340 Baar
Switzerland
tel: +41-41 767 34 34
19. Hoffmann La Roche F. AG
Dr Franz Humer
Grenzacherstr. 124
4070 B�le
Switzerland
Tel: +41-61 688 11 11
20. Novartis AG
Dr Daniel VASELLA
Case postale
4002 B�le
Switzerland
SORTED BY COUNTRY With parent company or new merged name in (red)
South Africa
The Pharmaceutical Manufacturers� Association of South Africa: South Africa
S.A. Scientific Pharmaceuticals (Proprietary) Limited: South Africa
Universal Pharmaceuticals (Proprietary) Limited: South Africa
Xixia Pharmaceuticals (Proprietary) Limited: South Africa (now owned by Merck)
US
Alcon Laboratories (S.A.) (Proprietary) Limited: USA
Bristol-Myers Squibb (Proprietary) Limited: USA
Eli Lilly (South Africa) (Proprietary) Limited: USA
Merck (Proprietary) Limited: US
MSD (Proprietary) Limited: (Merck, Sharp & Dohme): US (Merck)
Pharmacia & Upjohn (Proprietary) Limited: US
Schering (Proprietary) Limited: US (Schering-Plough)
Schering-Plough (Proprietary) Limited: US
Wyeth (Proprietary) Limited: US
Bristol-Myers Squibb Company: US
Eli Lilly and Company: US
Merck KgaA: US (Merck)
Merck & Co., Inc.: US (Merck)
Germany
Bayer (Proprietary) Limited: Germany
Ingelheim Pharmaceuticals (Proprietary) Limited: Germany (Boehringer-Ingelheim)
Knoll Pharmaceuticals South Africa (Proprietary) Limited: Germany
Bayer AG: Germany
Boehringer-Ingelheim International GmbH: Germany
Boehringer-Ingelheim KG: Germany
Byk Madaus (Proprietary) Limited: South Africa (subsidiary of Byk
Gulden, Germany)
Byk Gulden Lomberg Chemische Fabrik GmbH: Germany
Dr. Karl Thomae GmbH: Germany (Boehringer-Ingelheim)
UK
Glaxo Wellcome (South Africa) (Proprietary) Limited: UK (GlaxoSmithKline)
SmithKline Beecham Pharmaceuticals (Proprietary) Limited: UK (GlaxoSmithKline)
Zeneca South Africa (Proprietary) Limited: UK (AstraZeneca)
SmithKline Beecham: UK (GlaxoSmithKline)
France:
Hoecsht Marion Roussel Limited: France (Aventis)
Rhone-Poulenc Rorer South Africa (Proprietary) Limited: France (Aventis)
Rhone-Poulenc Rorer S.A.: France (Aventis)
Belgium
Janssen-Cilag Pharmaceutica (Proprietary) Limited: Belgium and Switzerland
Denmark
Lundbeck South Africa (Proprietary) Limited: Denmark
Novo Nordisk (Proprietary) Limited: Denmark
Switzerland-4
Janssen-Cilag Pharmaceutica (Proprietary) Limited: Belgium and Switzerland
Novartis South Africa (Proprietary) Limited: Switzerland
Roche Products (Proprietary) Limited: Switzerland (Roche)
F. Hoffman-La Roche AG: Switzerland